MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Biomarkers
Caprotec Bioanalytics
Parents
*Architects: Biotechnology_Biomarkers
*Industry: Germany
Architects: Biotechnology_Proteomics
Venture Capital: Series B
Children
Amt: 7.2M Round: Series B
Caprotec Bioanalytics focuses on the commercialization of its proprietary Capture Compound Mass Spectrometry (CCMS) technology in the areas of functional proteomics, drug development and development of biomarkers.
Commercial-stage Biopharmaceutical Company Focused on a Capture Compound Mass Spectrometry Technology Based on Multifunctional Small Molecules Used to Target, Capture, and Isolate Proteins
Industry: Drug Development Sub-Industry: N/A
Investor(s) LBBW Venture Capital, KfW Mittelstandsbank, Creathor Venture, IBB Beteiligungsgesellschaft
Series B $1.4M by OnBioVC (2011)
Jumps
Mass Spectrometry